SCHOTT Pharma AG & Co. KGaA (IT:1SXP)
:1SXP
Italy Market
Advertisement

SCHOTT Pharma AG & Co. KGaA (1SXP) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

1SXP Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
SCHOTT
Pharma AG & Co. KGaA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1SXP Stock 12 Month Forecast

Average Price Target

€28.00
▲(40.42% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for SCHOTT Pharma AG & Co. KGaA in the last 3 months. The average price target is €28.00 with a high forecast of €28.00 and a low forecast of €28.00. The average price target represents a 40.42% change from the last price of €19.94.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"€20","25":"€25","30":"€30","22.5":"€22.5","27.5":"€27.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€28.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,22.5,25,27.5,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jun<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.55,22.046153846153846,22.54230769230769,23.03846153846154,23.534615384615385,24.03076923076923,24.526923076923076,25.023076923076925,25.51923076923077,26.015384615384615,26.51153846153846,27.00769230769231,27.503846153846155,{"y":28,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.55,22.046153846153846,22.54230769230769,23.03846153846154,23.534615384615385,24.03076923076923,24.526923076923076,25.023076923076925,25.51923076923077,26.015384615384615,26.51153846153846,27.00769230769231,27.503846153846155,{"y":28,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.55,22.046153846153846,22.54230769230769,23.03846153846154,23.534615384615385,24.03076923076923,24.526923076923076,25.023076923076925,25.51923076923077,26.015384615384615,26.51153846153846,27.00769230769231,27.503846153846155,{"y":28,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.75,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":29.75,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":28.5,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":27.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.55,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€28.00Average Price Target€28.00Lowest Price Target€28.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DZ BANK AG Analyst forecast on IT:1SXP
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
10/31/25
SCHOTT Pharma AG & Co. KGaA (1SXP) Receives a Buy from DZ BANK AG
Barclays
€28
Buy
40.42%
Upside
Reiterated
10/14/25
Barclays Reaffirms Their Buy Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
Deutsche Bank  Analyst forecast on IT:1SXP
Deutsche Bank
Deutsche Bank
€31€29
Buy
45.44%
Upside
Reiterated
08/13/25
Deutsche Bank Keeps Their Buy Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
UBS
€29.2
Buy
46.44%
Upside
Reiterated
08/12/25
UBS Keeps Their Buy Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
Jefferies Analyst forecast on IT:1SXP
Jefferies
Jefferies
€24.3
Hold
21.87%
Upside
Reiterated
08/12/25
SCHOTT Pharma AG & Co. KGaA (1SXP) Receives a Hold from Jefferies
Berenberg Bank Analyst forecast on IT:1SXP
Berenberg Bank
Berenberg Bank
€27
Hold
35.41%
Upside
Reiterated
05/29/25
Berenberg Bank Reaffirms Their Hold Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DZ BANK AG Analyst forecast on IT:1SXP
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
10/31/25
SCHOTT Pharma AG & Co. KGaA (1SXP) Receives a Buy from DZ BANK AG
Barclays
€28
Buy
40.42%
Upside
Reiterated
10/14/25
Barclays Reaffirms Their Buy Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
Deutsche Bank  Analyst forecast on IT:1SXP
Deutsche Bank
Deutsche Bank
€31€29
Buy
45.44%
Upside
Reiterated
08/13/25
Deutsche Bank Keeps Their Buy Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
UBS
€29.2
Buy
46.44%
Upside
Reiterated
08/12/25
UBS Keeps Their Buy Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
Jefferies Analyst forecast on IT:1SXP
Jefferies
Jefferies
€24.3
Hold
21.87%
Upside
Reiterated
08/12/25
SCHOTT Pharma AG & Co. KGaA (1SXP) Receives a Hold from Jefferies
Berenberg Bank Analyst forecast on IT:1SXP
Berenberg Bank
Berenberg Bank
€27
Hold
35.41%
Upside
Reiterated
05/29/25
Berenberg Bank Reaffirms Their Hold Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering SCHOTT Pharma AG & Co. KGaA

1 Month
xxx
Success Rate
0/3 ratings generated profit
0%
Average Return
-7.60%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -7.60% per trade.
3 Months
xxx
Success Rate
0/3 ratings generated profit
0%
Average Return
-17.10%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -17.10% per trade.
1 Year
Success Rate
0/3 ratings generated profit
0%
Average Return
-23.47%
reiterated a buy rating last month
Copying Pallav Mittal's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -23.47% per trade.
2 Years
xxx
Success Rate
0/3 ratings generated profit
0%
Average Return
-23.47%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -23.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1SXP Analyst Recommendation Trends

Rating
May 25
Jun 25
Jul 25
Aug 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
0
0
2
6
8
Hold
1
2
2
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
4
9
10
In the current month, 1SXP has received 8 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 1SXP average Analyst price target in the past 3 months is 28.00.
Each month's total comprises the sum of three months' worth of ratings.

1SXP Financial Forecast

1SXP Earnings Forecast

The previous quarter’s earnings for 1SXP were €0.30.
The previous quarter’s earnings for 1SXP were €0.30.

1SXP Sales Forecast

The previous quarter’s earnings for 1SXP were €256.46M.
The previous quarter’s earnings for 1SXP were €256.46M.

1SXP Stock Forecast FAQ

What is IT:1SXP’s average 12-month price target, according to analysts?
Based on analyst ratings, SCHOTT Pharma AG & Co. KGaA’s 12-month average price target is 28.00.
    What is IT:1SXP’s upside potential, based on the analysts’ average price target?
    SCHOTT Pharma AG & Co. KGaA has 40.42% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SCHOTT Pharma AG & Co. KGaA a Buy, Sell or Hold?
          SCHOTT Pharma AG & Co. KGaA has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
            What is SCHOTT Pharma AG & Co. KGaA’s share price target?
            The average share price target for SCHOTT Pharma AG & Co. KGaA is 28.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €28.00 ,and the lowest forecast is €28.00. The average share price target represents 40.42% Increase from the current price of €19.94.
              What do analysts say about SCHOTT Pharma AG & Co. KGaA?
              SCHOTT Pharma AG & Co. KGaA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of SCHOTT Pharma AG & Co. KGaA?
                To buy shares of IT:1SXP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis